摘要
目的探究并分析微血管减压术治疗脑神经血管压迫综合征的临床效果。方法选取荆州市中心医院于2008年12月至2012年2月收治的脑神经血管压迫综合征患者90例,依据随机数字表法分为两组,各45例,微血管减压组采用微血管减压术进行治疗,药物组采用软化血管药物卡马西平进行治疗。治疗后,观察两组患者治愈情况及复发情况,对临床疗效进行比较分析。结果微血管减压组的治愈率显著高于药物组(P<0.05),且治疗2个月、3个月后复发率显著低于药物组(0%vs 26.67%,6.67%vs 37.78%,P<0.05)。结论微血管减压术治疗脑神经血管压迫综合征疗效确切,复发率低,值得临床推广。
Objective To explore and analyze the clinical effects of microvaseular decompression （MVD） in the treatment of brain vascular compression syndrome. Methods Ninty patients from Jingzhou Central Hospital from December 2008 to February 2012 treated for brain vascular compression syndrome were selected and randomly divided into two groups, the test group（ n = 45 ）were treated by microvascular decom- pression, the control group （n = 45 ）with vascular softening drug carbamazepine. The cure and recurrence of the two groups were observed, and a comparative analysis of the clinical efficacy was done. Results The cure rate of the test group,was higher than the control group（P 〈 0.05 ）, recurrence rate after two months, three months treatment was significantly lower than the control group （0% vs 26. 67%, 6. 67% vs 37.78% ）, with statistically significant difference（ P 〈 0.05 ）. Conclusion Microvascular decompression for the treatment of brain vascular compression syndrome has affirmative effect, low recurrence rate, which is worth promoting.
出处
《医学综述》
2013年第21期4007-4008,共2页
Medical Recapitulate
关键词
微血管减压术
脑神经压迫综合征
临床效果
卡马西平
Microvascular decompression
Cranial nerve compression syndrome
Clinical effect
Carbamazepine
